News
The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...
Facing another 61,000 unresolved lawsuits claiming its weedkiller causes cancer, Bayer added $1.2 billion to its glyphosate ...
Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.
Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...
Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...
The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July ...
1d
Zacks Investment Research on MSNBayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View
Bayer AG (BAYRY) reported second-quarter 2025 core earnings of 35 cents per American Depositary Receipt (ADR), which ...
Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...
We affirm our objective to significantly contain the litigation risk by the end of 2026,” CEO Bill Anderson noted said. As part of its ...
As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...
Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...
The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results